Trump fined $200 for failing to disclose tens of millions of dollars in stock trades on time
BlockBeats News, on May 15, according to The Washington Post, U.S. President Donald Trump failed to disclose tens of millions of dollars in stock transactions involving Microsoft, Amazon, and other companies within the statutory period, with a delay of several months. According to the latest investment filing, he was fined $200 as a result.
The report noted that these transactions involved multiple large-cap technology and financial stocks, with disclosed information indicating asset operations on the order of "tens of millions of dollars." The delay in filing has sparked external concern over whether he is strictly abiding by federal financial disclosure regulations.
According to requirements of the U.S. Office of Government Ethics, federal officials must report major financial transactions within the prescribed period, but in practice there are certain delays and relatively light penalties.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Crypto prices
More
